Odyssey Health, Inc.
ODYY
$0.05
$0.00-0.81%
OTC PK
| 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 168.65% | -65.33% | -85.95% | -29.59% | -126.78% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 165.59% | -65.33% | -86.47% | -31.50% | -136.24% |
| Operating Income | -165.59% | 65.33% | 86.47% | 31.50% | 136.24% |
| Income Before Tax | 98.02% | 70.12% | -101.66% | -89.39% | -1,465.05% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 98.02% | 70.12% | -101.66% | -89.39% | -1,465.05% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 98.02% | 70.12% | -101.66% | -89.39% | -1,465.05% |
| EBIT | -165.59% | 65.33% | 86.47% | 31.50% | 136.24% |
| EBITDA | -165.42% | 65.44% | 86.50% | 31.48% | 136.29% |
| EPS Basic | 98.03% | 70.37% | -101.46% | -46.97% | -1,166.67% |
| Normalized Basic EPS | -244.44% | 62.07% | 85.23% | 51.25% | 115.00% |
| EPS Diluted | 92.12% | 76.00% | -101.79% | 0.00% | -1,132.04% |
| Normalized Diluted EPS | -244.44% | 62.07% | 81.69% | 51.25% | 115.00% |
| Average Basic Shares Outstanding | -0.05% | 0.89% | 13.85% | 29.27% | 22.96% |
| Average Diluted Shares Outstanding | -0.05% | 0.89% | -8.19% | 29.24% | 22.96% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |